Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 9, 2008, Pages 2488-2497

  Sakko, Andrew J ^a   Butler, Miriam S ^a   Byers, Sharon ^a,b   Reinboth, Betty J ^a   Stahl, Jürgen ^c   Kench, James G ^d,e   Horvath, Lisa G ^d,f   Sutherland, Robert L ^f   Stricker, Phillip D ^d,g   Henshall, Susan M ^d   Marshall, Villis R ^h   Tilley, Wayne D ^a   Horsfall, David J ^a   Ricciardelli, Carmela ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Department of Genetic Medicine

^c Adelaide Pathology Partners   (Australia)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g ST VINCENT S HOSPITAL   (Australia)

^h ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; DISACCHARIDE; EPITOPE; GLYCOSAMINOGLYCAN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER TISSUE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RELAPSE; SCORING SYSTEM; STAINING; STROMA; SULFATION; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; CHONDROITIN; DISACCHARIDES; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 53349141222     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0204     Document Type: Article

References (39)

1. Hoedemaeker RF, Vis AN, Van Der Kwast TH. Staging prostate cancer. Microsc Res Tech 2000;51:423-9.
2. Ayala G, Tuxhorn JA, Wheeler TM, et al. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin Cancer Res 2003;9:4792-801.
3. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Leveling of prostate cancer mortality in Western Europe. Prostate 2004;60:46-52.
4. Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD. Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Database Syst Rev 2006:CD006019.
5. Walczak JR, Carducci MA. Prostate cancer: a practical approach to current management of recurrent disease. Mayo Clin Proc 2007;82:243-9.
6. Yip GW, Smollich M, Gotte M. Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 2006;5:2139-48.
7. Adany R, Heimer R, Caterson B, Sorrell JM, Iozzo RV. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J Biol Chem 1990;265:11389-96.
8. Dietrich CP, Martins JR, Sampaio LO, Nader HB. Anomalous structure of urinary chondroitin sulfate from cancer patients. A potential new marker for diagnosis of neoplasias. Lab Invest 1993;68:439-45.
9. Martins RC, Lima FR, Werneck CC, Neto VM, Silva LC. Patterns of synthesis and secretion of sulfated glycosaminoglycans in primary cortical and cerebellar astrocytes in vitro. Biol Cell 2000;92:421-7.
10. Theocharis AD, Tsara ME, Papageorgacopoulou N, Karavias DD, Theocharis DA. Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition. Biochim Biophys Acta 2000;1502:201-6.
11. De Klerk DP, Lee DV, Human HJ. Glycosaminoglycans of human prostatic cancer. J Urol 1984;131:1008-12.
12. Iida S, Suzuki K, Matsuoka K, et al. Analysis of glycosaminoglycans in human prostate by high-performance liquid chromatography. Br J Urol 1997;79:763-9.
13. Ricciardelli C, Mayne K, Sykes PJ, et al. Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. Clin Cancer Res 1997;3:983-92.
14. Ricciardelli C, Quinn DI, Raymond WA, et al. Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer. Cancer Res 1999;59:2324-8.
15. Mark MP, Baker JR, Kimata K, Ruch JV. Regulated changes in chondroitin sulfation during embryogenesis: an immunohistochemical approach. Int J Dev Biol 1990;34:191-204.
16. Silbert JE, Sugumaran G. Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life 2002;54:177-86.
17. Kitagawa H, Tsutsumi K, Tone Y, Sugahara K. Developmental regulation of the sulfation profile of chondroitin sulfate chains in the chicken embryo brain. J Biol Chem 1997;272:31377-81.
18. Kovalszky JTaI. Differential expression of proteoglycans on the surface of malignant cells and in the tumor stroma. In: Adany R, editor. Tumor matrix biology. Boca Raton (FL): CRC Press; 1995. p. 23-53.
19. Tsara ME, Papageorgacopoulou N, Karavias DD, Theocharis DA. Distribution and changes of glycosaminoglycans in neoplasias of rectum. Anticancer Res 1995;15:2107-12.
20. Hermanek P. 1992 tumor classification/developments. Langenbecks Arch Chir Suppl Kongressbd 1992;:40-45.
21. Couchman JR, Caterson B, Christner JE, Baker JR. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature 1984;307:650-2.
22. Horsfall DJ, Mayne K, Skinner JM, Saccone GT, Marshall VR, Tilley WD. Glycosaminoglycans of guinea pig prostate fibromuscular stroma: influence of estrogen and androgen on levels and location of chondroitin sulfate. Prostate 1994;25:320-32.
23. Reinboth BJ, Finnis ML, Gibson MA, Sandberg LB, Cleary EG. Developmental expression of dermatan sulfate proteoglycans in the elastic bovine nuchal ligament. Matrix Biol 2000;19:149-62.
24. Zebrower M, Kieras FJ, Heaney-Kieras J. High pressure liquid chromatographic identification of hyaluronic acid and chondroitin sulphate disaccharides. Glycobiology 1991;1:271-6.
25. Ricciardelli C, Mayne K, Sykes PJ, et al. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 1998;4:963-71.
26. Skandalis SS, Stylianou M, Vynios DH, Papageorgakopoulou N, Theocharis DA. The structural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer. Biochimie 2007;89:1573-80.
27. Kovalszky I, Pogany G, Molnar G, et al. Altered glycosaminoglycan composition in reactive and neoplastic human liver. Biochem Biophys Res Commun 1990;167:883-90.
28. Theocharis AD, Vynios DH, Papageorgakopoulou N, Skandalis SS, Theocharis DA. Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int J Biochem Cell Biol 2003;35:376-90.
29. Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN. Effects of platelet-derived growth factor and transforming growth factor-β1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 1991;266:17640-7.
30. Thiebot B, Bichoualne L, Langris M, et al. IGF-1 stimulates synthesis of undersulfated proteoglycans and of hyaluronic acid by peritubular cells from immature rat testis. Biochim Biophys Acta 1997;1358:127-41.
31. Hirota M, Egami H, Ogawa M. Augmentation of UDP-GalNAc: Fucα1-2Gal α1-3 N-acetylgalactosaminyl transferase activity in nitrosamine-induced hamster pancreatic cancers. J Exp Clin Cancer Res 2000;19:235-9.
32. Sakko AJ, Ricciardelli C, Mayne K, et al. Modulation of prostate cancer cell attachment to matrix by versican. Cancer Res 2003;63:4786-91.
33. Newgreen DF, Gibbins IL, Sauter J, Wallenfels B, Wutz R. Ultrastructural and tissue-culture studies on the role of fibronectin, collagen and glycosaminoglycans in the migration of neural crest cells in the fowl embryo. Cell Tissue Res 1982;221:521-49.
34. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992;6:861-70.
35. Sorrell JM, Carrino DA, Baber MA, Caplan AI. Versican in human fetal skin development. Anat Embryol (Berl) 1999;199:45-56.
36. Shimazaki Y, Nagata I, Ishii M, et al. Developmental change and function of chondroitin sulfate deposited around cerebellar Purkinje cells. J Neurosci Res 2005;82:172-83.
37. Mizuguchi S, Uyama T, Kitagawa H, et al. Chondroitin proteoglycans are involved in cell division of Caenorhabditis elegans. Nature 2003;423:443-8.
38. Pratt T, Conway CD, Tian NM, Price DJ, Mason JO. Heparan sulphation patterns generated by specific heparan sulfotransferase enzymes direct distinct aspects of retinal axon guidance at the optic chiasm. J Neurosci 2006;26:6911-23.
39. Shipp EL, Hsieh-Wilson LC. Profiling the sulfation specificities of glycosaminoglycan interactions with growth factors and chemotactic proteins using microarrays. Chem Biol 2007;14:195-208.